About macrolides use in lower respiratory tract infections in children


Citar

Texto integral

Resumo

The article provides an overview of the frequency and diagnostic features of infections caused by mycoplasma and chlamydia in children. The importance of clinical diagnosis of such pneumonia and bronchitis bring into focus, because the high rate of carrier state and delayed rising antibody titer aggravate diagnosis in early disease. Clinical manifestations of mycoplasmal pneumonia and bronchitis and pneumonia caused by Chlamydia trachomatis in infants are sufficient for the correct empirical choice of antibiotic. Lack of treatment efficacy of pneumonia by beta-lactam antibiotics is important for further diagnosis. Drug of choice for treatment of "atypical" infections is azithromycin.

Bibliografia

  1. Сидоренко С.В., Грудинина С.А., Филимонова О.Ю. и др. Резистентность к макролидам и линкозамидам среди Streptococcus pneumoniae и Streptococcus pyogenes в Российской Федерации // Клиническая фармакология и терапия 2008. Т. 17. № 2. С. 1-4.
  2. Marra F, Patrick DM, Chong M, Bowie WR. Antibiotic use among children in British Columbia, Canada. J Antimicrob Chemother 2006;58(4):830-39.
  3. Stille CJ, Andrade SE, Huang SS, et al. Increased use of second-generation macrolide antibiotics for children in nine health plans in the United States. Pediatrics 2004;114(5):1206-11.
  4. Бондарь Г.Н., Лучанинова В.Н. Применение антибактериальных препаратов у детей при острых респираторных инфекциях в амбулаторной практике Владивостока // Педиатрическая фармакология. 2007. Т. 4. № 1. С. 19-22.
  5. Ochoa C, Inglada L, Eiros JM, et al. Spanish Study Group on Antibiotic Treatments. Appropriateness of antibiotic prescriptions in community-acquired acute pediatric respiratory infections in Spanish emergency rooms. Pediatr Infect Dis J 2001;20(8):751-58.
  6. Tjhie JH, Dorigo-Zetsma JW, Roosendaal R. Chlamydia pneumoniae and Mycoplasma pneumoniae in children with acute respiratory infection in general practices in The Netherlands. Scand J Infect Dis 2000;32(1):13-7.
  7. Defilippi A, Silvestri M, Tacchella A, et al. Epidemiology and clinical features of Mycoplasma pneumoniae infection in children Respir Med 2008;102(12):1762-68.
  8. Marguet C. Bronchopulmonary infections in the infant and the child. Rev Prat 2007;57(11):1237-44.
  9. Мизерницкий Ю.Л., Сорокина Е.В. Макролиды при инфекциях дыхательных путей у детей: современные представления о механизмах действия // Consilium medicum (Педиатрия). 2006. № 2. С. 23-26.
  10. Heiskanen-Kosma T, Korppi M, Jokinen C, et al. Etiology of childhood pneumonia: serologic results of a prospective, population-based study . Pediatr Infect Dis J 1998;17(11):986-99.
  11. Wubbel L, Muniz L, Ahmed A, et al. Etiology and treatment of community-acquired pneumonia in ambulatory children Pediatr Infect Dis J 1999;18(2):98-104.
  12. Bamba M, Jozaki K, Sugaya N, et al. Prospective surveillance for atypical pathogens in children with community-acquired pneumonia in Japan. Infect Chemother 2006;12(1):36-41.
  13. Gaillat J, Flahault A, deBarbeyrac B, et al. Community epidemiology of Chlamydia and Mycoplasma pneumoniae in LRTI in France over 29 months. Eur J Epidemiol 2005;20(7):643-51.
  14. Острые пневмонии у детей / Под ред. В.К. Таточенко. Чебоксары. 1994.
  15. Martinez MA, Millan F, Gonzalez C. Chlamydia trachomatis genotypes associated with pneumonia in Chilean infants. Scand J Infect Dis 2009;41(4):313-16.
  16. Nelson CT. Mycoplasma and Chlamydia pneumonia in pediatrics. Semin Respir Infect 2002;17(1):10-14.
  17. Principi N, Esposito S. Emerging role of Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric respiratory-tract infections. Lancet Infect Dis 2001;1(5):334-44.
  18. Gupta SK, Sarosi GA. The role of atypical pathogens in community-acquired pneumonia Med Clin North Am. 2001;85(6):1349-65.
  19. Попова Л.А. Острые респираторные заболевания в детских учреждениях // В кн.: Таточенко В.К., Рачинский С.В., Споров О.А. Острые заболевания органов дыхания у детей. М., 1981. С. 10-16.
  20. Nilsson AC, Bjоrkman P, Persson K. Polymerase chain reaction is superior to serology for the diagnosis of acute Mycoplasma pneumoniae infection and reveals a high rate of persistent infection. BMC Microbiol 2008;11(8):93.
  21. Таточенко В.К. Руководство по амбулаторно-поликлинической педиатрии. 2004. 2006.
  22. Hueston WJ, Mainous AG. Acute bronchitis. Am Fam Physician 1998;57(56):1270-84.
  23. Бурова А.А. Роль Chlamydia pneumoniae в этиологии острого бронхита у детей // Журнал микробиологии, эпидемиологии и иммунобиологии. 2001. № 4. С. 53-55.
  24. Blasi F, Tarsia P, Aliberti S. Chlamydophila pneumoniae. Clin Microbiol Infect 2009;15(1):29-35.
  25. Suttithawil W, Ploysongsang Y, Nunthapisud P, et al. Acute primary Chlamydophila pneumoniae bronchitis and bronchial hyperresponsiveness in young nonasthmatic Thai military recruits.Ann Allergy Asthma Immunol 2007;99(5):413-18.
  26. Федоров А.М. Щадящие методы диагностики и лечения острой пневмонии. Автореф. дисс. док. мед. наук. М., 1992.
  27. Schmidt SM, Mьller CE, Gьrtler L, et al. Chlamydophila pneumoniae respiratory tract infection aggravates therapy refractory bronchitis or pneumonia in childhood. Klin Padiatr 2005;217(1):9-14.
  28. Шамансурова Э.О. Респираторный хламидиоз у детей. Автореф. дисс. канд. мед. наук. М., 1988.
  29. Gavranich JB, Chang AB. Antibiotics for community acquired lower respiratory tract infections (LRTI) secondary to Mycoplasma pneumoniae in children. Cochrane Database Syst Rev 2005; 20(3):CD004875.
  30. Panpanich R, Lerttrakarnnon P, Laopaiboon M. Azithromycin for acute lower respiratory tract infections Cochrane Database Syst Rev 2008 Jan 23;(1):CD001954.
  31. Brookes-Howell L, Butler C, Hood K, et al. Attitudes and perceptions of doctors and patients to antibiotic use for LRTI in Europe. ESCMID, Helsinki 16-19 May 2009[S374].
  32. Страчунский Л.С. Устное сообщение. 2001.
  33. Наймушина Н.Б. Клиническая оценка роли гемофильной палочки в развитии острых заболеваний дыхательных путей у детей. Автореф. дисс. канд. мед. наук. М., 1986.
  34. Honein MA, Paulozzi MJ, Himeright IM, et al. Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromycin. A case rewiev and cohort study. Lancet 1999;354:2101-5.
  35. Morrison W. Infantile hypertrophic pyloric stenosis in infants treated with azithromycin. Pediatr Infect Dis J 2007;26(2):186-88.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies